Establishment and Characterization of Primary Glioblastoma Cell Lines from Fresh and Frozen Material: A Detailed Comparison
Open Access
- 7 August 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (8) , e71070
Abstract
Development of clinically relevant tumor model systems for glioblastoma multiforme (GBM) is important for advancement of basic and translational biology. High molecular heterogeneity of GBM tumors is well recognized, forming the rationale for molecular tests required before administration of several of the novel therapeutics rapidly entering the clinics. One model that has gained wide acceptance is the primary cell culture model. The laborious and time consuming process is rewarded with a relative high success rate (about 60%). We here describe and evaluate a very simple cryopreservation procedure for GBM tissue prior to model establishment that will considerably reduce the logistic complexity. Twenty-seven GBM samples collected ad hoc were prepared for primary cell culture freshly from surgery (#1) and after cryopreservation (#2). Take rates after cryopreservation (59%) were as satisfactory as from fresh tissue (63%; p = 1.000). We did not observe any relevant molecular or phenotypic differences between cell lines established from fresh or vitally frozen tissue. Further, sensitivity both towards standard chemotherapeutic agents (Temozolomide, BCNU and Vincristine) and novel agents like the receptor tyrosine kinase inhibitor Imatinib did not differ. Our simple cryopreservation procedure facilitates collection, long-time storage and propagation (modeling) of clinical GBM specimens (potentially also from distant centers) for basic research, (pre-) clinical studies of novel therapies and individual response prediction.Keywords
This publication has 26 references indexed in Scilit:
- In vivo models of primary brain tumors: pitfalls and perspectivesNeuro-Oncology, 2012
- Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor responseProceedings of the National Academy of Sciences, 2012
- Novel cell lines established from pediatric brain tumorsJournal of Neuro-Oncology, 2011
- Cryopreservation of cancer-initiating cells derived from glioblastomaFrontiers in Bioscience-Scholar, 2011
- Cryopreservation of human colorectal carcinomas prior to xenograftingBMC Cancer, 2010
- Adjuvant dendritic cell‐based tumour vaccination for children with malignant brain tumoursPediatric Blood & Cancer, 2009
- Postoperative Adjuvant Dendritic Cell–Based Immunotherapy in Patients with Relapsed Glioblastoma MultiformeClinical Cancer Research, 2008
- Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysisLaboratory Investigation, 2006
- Clonogenic assay with established human tumour xenograftsEuropean Journal of Cancer, 2004
- Primary and secondary glioblastomas: From concept to clinical diagnosisNeuro-Oncology, 1999